Loxo Oncology Inc. | Key People and Executives
Joshua H. Bilenker
President, Chief Executive Officer & Director
Keith T. Flaherty
Director
Alan Fuhrman
Independent Director
Tim M. Mayleben
Independent Director
Avi Z. Naider
Independent Director
Steven Arnote Elms
Independent Director
Joshua H. Bilenker
President, Chief Executive Officer & Director
Sara Slifka
VP-Business Operations & Program Management
Jennifer Burstein
Senior Vice President-Finance
Deborah Morosini
VP-Clinical Affairs & Patient Engagement
S. Michael Rothenberg
Vice President-Research & Development
Jacob S. van Naarden
Chief Business Officer
Michael Cox
Senior Director-Clinical Development
Nisha Nanda
Vice President-Strategy Development
Keith T. Flaherty
Director
Jennifer L. Kronick
Vice President-Human Resources
Katie Cairati
Executive Director-Regulatory Affairs
Steven D. Harr
Independent Director
Alan Fuhrman
Independent Director
Tim M. Mayleben
Independent Director
Avi Z. Naider
Independent Director
Steven Arnote Elms
Independent Director
| Address |
281 Tresser Boulevard
Stamford Connecticut 06901
United States
|
|
Employees
|
- |
| Website |
http://www.loxooncology.com |
| Updated |
09/14/2018 |
| Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. |
